Abstract As cancer therapies advance and patient survival improves, there has been growing concern about the long-term adverse effects that patients may experience following treatment, and concerns have been raised about such persistent, progressive, and often irreversible adverse effects
Publisher Responsibility: The publisher of this article has made every effort to ensure accuracy at the time of publication based on publicly available information
Somewhat surprisingly, in cytoplasm, IGF-1 gene therapy strengthened cytoplasm AKT1p53 interaction to inhibit H 2 O 2 -initiated p53 nuclear translocation
Finley says she still had to put in a lot of work to get healthy
10.1016/j.ejogrb.2013.11.008 99 KerrJ
Ph hp cho ngi t 10 tui tr ln, s dng 2 vin/ngy vo sng v ti sau ba n t hiu qu ti u